2560 General Armistead Ave
Audubon, Pennsylvania 19403-5214
Globus Medical is positioned to deliver tremendous EPS upside over the coming 3 quarters in our estimation. Click here for a full investment analysis of GMED stock.
Globus showed reacceleration and share growth in the U.S. spine market in the third quarter, as technology (robotics, imaging/navigation) continues to drive implant share growth.
GMED earnings call for the period ending September 30, 2022.
No summary available.
AUDUBON, Pa., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2022.
Globus Medical (NYSE: GMED ) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here''s what investors need to know before the announcement. Analysts estimate that Globus Medical will report an earnings per share (EPS) of $0.52. Globus Medical bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for … Full story available on Benzinga.com